| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.88B | +7.3% |
| Cost of Revenue | $15.38B | +4.2% |
| R&D Expense | $794.0M | +5.3% |
| SG&A Expense | $4.08B | +7.4% |
| Pre-tax Income | $4.57B | +19.3% |
| Income Tax | $768.0M | +27.2% |
| Net Income | $3.79B | +17.9% |
| EPS (Basic) | $9.54 | +18.4% |
| EPS (Diluted) | $9.50 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $555.0M | +13.7% |
| Short-term Investments | $1.52B | -28.1% |
| Accounts Receivable | $4.62B | +3.2% |
| Inventory | $4.23B | +13.1% |
| Current Assets | $11.80B | +1.1% |
| Total Assets | $38.38B | -0.1% |
| Current Liabilities | $7.86B | +1.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $4.33B | +19.4% |
| Capital Expenditures | $808.0M | +6.7% |
| Investing Cash Flow | -$271.0M | +89.5% |
| Financing Cash Flow | -$3.94B | -351.9% |
| Free Cash Flow | $3.52B | +22.7% |
| +18.5% |
| Long-term Debt |
| $9.15B |
| -1.2% |
| Stockholders' Equity | $18.49B | -2.9% |